zelebrudomide (NX-2127) / Nurix Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
zelebrudomide (NX-2127) / Nurix Therap
NX-2127-001, NCT04830137: A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Recruiting
1
248
US
NX-2127
Nurix Therapeutics, Inc.
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Follicular Lymphoma (FL), Diffuse Large B-cell Lymphoma (DLBCL), Primary Central Nervous System Lymphoma (PCNSL)
12/25
12/26

Download Options